Arrowstreet Capital
CLB icon

Arrowstreet Capital’s Core Laboratories CLB Stock Holding History

Arrowstreet Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-127,248
Closed -$1.94M – 2315
2020
Q3 		$1.94M Buy
+127,248
New +$2.67M ﹤0.01% 1568
2020
Q1 		– Sell
-95,123
Closed -$3.58M – 1892
2019
Q4 		$3.58M Buy
+95,123
New +$4.27M 0.01% 953
2018
Q1 		– Sell
-6,300
Closed -$690K – 1143
2017
Q4 		$690K Buy
+6,300
New +$629K ﹤0.01% 1024
2017
Q3 		– Sell
-2,000
Closed -$203K – 1118
2017
Q2 		$203K Buy
+2,000
New +$216K ﹤0.01% 995
2016
Q3 		– Sell
-35,100
Closed -$4.35M – 1493
2016
Q2 		$4.35M Sell
35,100
-26,660
-43% -$3.22M 0.01% 619
2016
Q1 		$6.94M Buy
61,760
+56,960
+1,187% +$5.92M 0.03% 465
2015
Q4 		$522K Sell
4,800
-34,300
-88% -$3.93M ﹤0.01% 1132
2015
Q3 		$3.9M Sell
39,100
-8,900
-19% -$968K 0.02% 602
2015
Q2 		$5.47M Buy
48,000
+32,000
+200% +$3.88M 0.03% 403
2015
Q1 		$1.67M Buy
+16,000
New +$1.7M 0.01% 625
2014
Q2 		– Sell
-43,982
Closed -$8.73M – 1005
2014
Q1 		$8.73M Buy
+43,982
New +$8.3M 0.05% 315

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Arrowstreet Capital's CLB Position: Q4 2020 in Review

Arrowstreet Capital sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 127,248 shares — an estimated $1.94M sold.

Arrowstreet Capital first reported a position in CLB in Q1 2014 and held it in 11 quarters. The position peaked at $8.73M in Q1 2014. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

  • Arrowstreet Capital reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 127,248 Core Laboratories shares in Q4 2020, an estimated $1.94M.
  • Arrowstreet Capital first reported a position in Core Laboratories in Q1 2014 and held it in 11 quarters.
  • Arrowstreet Capital's Core Laboratories position peaked at $8.73M in Q1 2014.
  • 181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Arrowstreet Capital's 13F filing for Q4 2020, filed 12 Feb 2021.